Fig. 1From: Intralymphatic immunotherapy induces allergen specific plasmablasts and increases tolerance to skin prick testing in a pilot studyImpact of ILIT on Symptom medication score (SMS) (a), nasal allergen challenge (NAC) (b), skin prick test diameter >3 mm (c) and allergen specific non-IgE (d) and IgE (e) plasma cell numbers 1 week after each allergen injection (Vn + 7d). Nonparametric tests were used to evaluate treatment effectBack to article page